Mwanzo2096 • HKG
add
Simcere Pharmaceutical Group Ltd
Bei iliyotangulia
$ 6.53
Bei za siku
$ 6.52 - $ 6.80
Bei za mwaka
$ 4.94 - $ 7.87
Thamani ya kampuni katika soko
17.08B HKD
Wastani wa hisa zilizouzwa
6.10M
Uwiano wa bei na mapato
-
Mgao wa faida
2.60%
Ubadilishanaji wa msingi
HKG
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (CNY) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 1.56B | -7.93% |
Matumizi ya uendeshaji wa biashara | 939.63M | -14.71% |
Mapato halisi | 228.30M | -79.92% |
Kiwango cha faida halisi | 14.66 | -78.19% |
Mapato kwa kila hisa | — | — |
EBITDA | 345.55M | 47.98% |
Asilimia ya kodi ya mapato | 7.70% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (CNY) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 3.06B | 24.38% |
Jumla ya mali | 11.71B | -7.70% |
Jumla ya dhima | 4.80B | 32.12% |
Jumla ya hisa | 6.91B | — |
hisa zilizosalia | 2.54B | — |
Uwiano wa bei na thamani | 2.40 | — |
Faida inayotokana na mali | 6.22% | — |
Faida inayotokana mtaji | 9.00% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (CNY) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 228.30M | -79.92% |
Pesa kutokana na shughuli | 431.33M | 1,152.84% |
Pesa kutokana na uwekezaji | -200.98M | -129.73% |
Pesa kutokana na ufadhili | 143.27M | 159.16% |
Mabadiliko halisi ya pesa taslimu | 373.91M | -5.19% |
Mtiririko huru wa pesa | 215.87M | 112.26% |
Kuhusu
Simcere Pharmaceutical Group or Simcere Pharmaceutical is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market. Its focus is to introduce generic and pharmaceutical products for the treatment of diseases with high incidence and/or mortality rate. The Company has introduced a generic anti-stroke medication under the brand name, Bicun, and an anti-cancer medication under the brand name, Endu. Its products include antibiotics, anti-stroke medications, anti-inflammatory drugs, anti-cancer medications and other medicines. In addition, it has obtained approvals from the China State Food and Drug Administration to manufacture and sell over 210 other products. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1995
Makao Makuu
Tovuti
Wafanyakazi
6,412
